Page last updated: 2024-09-04

h 1356 and fulvestrant

h 1356 has been researched along with fulvestrant in 1 studies

Compound Research Comparison

Studies
(h 1356)
Trials
(h 1356)
Recent Studies (post-2010)
(h 1356)
Studies
(fulvestrant)
Trials
(fulvestrant)
Recent Studies (post-2010) (fulvestrant)
15092,7122071,196

Protein Interaction Comparison

ProteinTaxonomyh 1356 (IC50)fulvestrant (IC50)
Estrogen receptorHomo sapiens (human)0.0061
Estrogen receptorRattus norvegicus (Norway rat)0.0059
Progesterone receptorHomo sapiens (human)0.0002
Steroid hormone receptor ERR1Homo sapiens (human)0.002
Bifunctional epoxide hydrolase 2Homo sapiens (human)0.006
Estrogen receptor betaHomo sapiens (human)0.0104
Bile acid receptorHomo sapiens (human)0.79
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)2.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, VJ; Kawano, Y; Kypta, RM; Lanyon, LE; Price, JS; Sunters, A; Zaman, G1

Other Studies

1 other study(ies) available for h 1356 and fulvestrant

ArticleYear
Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 recept
    The Journal of biological chemistry, 2010, Mar-19, Volume: 285, Issue:12

    Topics: Animals; beta Catenin; Binding Sites; Bone and Bones; Estradiol; Estrogen Receptor alpha; Fulvestrant; Insulin-Like Growth Factor I; LDL-Receptor Related Proteins; Low Density Lipoprotein Receptor-Related Protein-5; Nitric Oxide; Oligopeptides; Osteoblasts; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2010